Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity

Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity

Patients suffering from acute myeloid leukemia (AML) show highly heterogeneous clinical outcomes. Next to variabilities in patient-specific parameters influencing treatment decisions and outcome, this is due to differences in AML biology. In fact, different genetic drivers may transform variable cel...

Full description

Bibliographic Details
Main Authors: Marlon Arnone, Martina Konantz, Pauline Hanns, Anna M. Paczulla Stanger, Sarah Bertels, Parimala Sonika Godavarthy, Maximilian Christopeit, Claudia Lengerke
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
acute myeloid leukemia
leukemic stem cells
cellular heterogeneity
markers
relapse
Online Access:https://www.mdpi.com/2072-6694/12/12/3742

Internet

https://www.mdpi.com/2072-6694/12/12/3742

Similar Items